4th TAB-in Sessions during the European Nanomedicine Meeting 2017 in London
4 April 2017 - 4 April 2017
United Kingdom
The Nanomedicine Translation Advisory Board (NanomedTAB) is a tool implemented by the ENATRANS CSA which offers a free-of-charge mentoring program to promising nanomedicine teams and projects at any stage of development to assess, advise and accelerate their translation and get to commercial application faster and more reliably. To reach this objective, the TAB counts on 11 experts from industry, specifically recruited for their diverse, extensive and complementary experience in the translation of innovative technologies for healthcare applications.
The current statistics of the cases supported by the TAB experts are very promising with 52 teams from 16 countries already having applied, and about half of them being currently benefiting from the experts’ continuous coaching.
Applications to the TAB should be submitted before 27th February 2017 through the following link: http://www.nanomedtab.eu/?apply.(opens in new window)
Information about the European Nanomedicine Meeting 2017 can be found on the event's website at http://www.britishsocietynanomedicine.org/enm-2017-conference1.html(opens in new window)
The current statistics of the cases supported by the TAB experts are very promising with 52 teams from 16 countries already having applied, and about half of them being currently benefiting from the experts’ continuous coaching.
Applications to the TAB should be submitted before 27th February 2017 through the following link: http://www.nanomedtab.eu/?apply.(opens in new window)
Information about the European Nanomedicine Meeting 2017 can be found on the event's website at http://www.britishsocietynanomedicine.org/enm-2017-conference1.html(opens in new window)
Keywords
Nanomedicine, Translation, Translation Advisory Board, ENATRANS